Tenaya Therapeutics (NasdaqGS:TNYA) FY Conference Transcript

Tenaya Therapeutics (NasdaqGS:TNYA) FY Conference October 21, 2025 12:00 PM ET Speaker3I'm Gula Lifschitz, a biotech analyst at Chardan, and welcome to this session on cardiac gene therapy. The space now has several programs that have delivered some exciting proof-of-concept data. As with other segments in the space, there have been some setbacks. For example, safety signals in the adenosine therapy program and discussion about the extent of read-through on risks from other systemically administered gene th ...